Steven Cohen Crispr Therapeutics Ag Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$36.68 - $73.13 $236,806 - $472,127	-6,456 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$40.99 - $52.56 $24,594 - $31,536	-600 Reduced 8.5%	6,456 $265,000
Q2 2019 Aug 14, 2019	BUY	$35.45 - $48.2 $89,723 - $121,994	2,531 Added 55.93%	7,056 $332,000
Q1 2019 May 15, 2019	BUY	$28.02 - $40.87 $126,790 - $184,936	4,525 New	4,525 $162,000

499

56.8M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.03B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.